Piercey M F, Lum J T, Hoffmann W E, Carlsson A, Ljung E, Svensson K
Upjohn Co., Kalamazoo, MI 49001.
Brain Res. 1992 Aug 21;588(2):217-22. doi: 10.1016/0006-8993(92)91578-3.
The aminotetralins (+)-AJ76 and (+)-UH232 are stimulant dopaminergic antagonists, which may preferentially antagonize autoreceptors of dopamine nerve terminals. Both agents antagonized cocaine's depressant effects on firing rates of ventral tegmental dopaminergic neurons, but (+)-UH232 was much more potent. When injected simultaneously with cocaine, (+)-UH232 inhibited and (+)-AJ76 enhanced the locomotor stimulation observed during the first 30 min following s.c. cocaine administration. However, (+)-AJ76 antagonized cocaine-induced stereotypies as well as the later more intense cocaine locomotor stimulation. It is suggested that preferential dopamine autoreceptor antagonists may provide a novel approach to a pharmacotherapy for treating cocaine abuse.
氨基四氢萘类化合物(+)-AJ76和(+)-UH232是刺激性多巴胺能拮抗剂,它们可能优先拮抗多巴胺神经末梢的自身受体。这两种药物都拮抗可卡因对腹侧被盖区多巴胺能神经元放电率的抑制作用,但(+)-UH232的效力要强得多。当与可卡因同时注射时,(+)-UH232抑制而(+)-AJ76增强了皮下注射可卡因后最初30分钟内观察到的运动刺激。然而,(+)-AJ76拮抗可卡因诱导的刻板行为以及后期更强的可卡因运动刺激。有人提出,优先的多巴胺自身受体拮抗剂可能为治疗可卡因滥用的药物疗法提供一种新方法。